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Shortening the Duration of Antimicrobial Therapy in
Uncomplicated Skin and Soft Tissue Infections
Alicia Daggett, MD, MPH and Brandi Missel, MSN, RN, CPNP
Children’s Mercy Kansas Hospital, Overland Park, KS

Background and Aim

Methods

Background:
Skin and soft tissue infections (SSTIs) are common occurrences in
children. The "Practice Guidelines for the Diagnosis and Management of
Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases
Society of America" states the "recommended duration of antimicrobial
therapy is 5 days, but treatment should be extended if the infection has
not improved w ithin this time period (strong recommendation, high
quality evidence)." Short course antimicrobial therapy for SSTIs may be
beneficial to prevent development of resistant bacteria, increase costeffectiveness of therapy and reduce side effects of antimicrobial therapy.

1. Educated providers regarding recommendations including exclusion/inclusion criteria because there w ere
know ledge gaps identified in a preliminary survey of providers. Information w as posted in an easily visible
place in the w orkroom and presented regularly at staff meetings.
2. Completed chart reviews regularly to evaluate missed opportunities to prescribe shorter duration of
antibiotics for uncomplicated SSTIs.
3. System modifications completed to help promote compliance w ith shorter duration therapy for SSTIs.
Developed an antibiotic shortcut folder within the EMR w ith pre-filled treatment durations for shorter courses of
antibiotics, as this intervention w orked well in the past.
4. Distributed monthly summaries to individual providers to show performance regarding treatment of SSTIs
and highlight success in meeting the project goals. Providers requested this data for review.
5. Ensured failure rates for short course antibiotic treatment did not exceed that of the previously prescribed
longer duration antibiotics. Collected data on patients returning w ithin 28 days of initial visit to any Children's
Mercy location and admitted for IV antibiotics. Baseline failure rate w as 1%.

Problem:
Children treated for SSTIs at Children's Mercy Kansas Hospital ED (CMK
ED) often receive longer duration antimicrobial therapy (7-14 days) w ith
variable recommendations for follow-up. Initially, 4% of children treated
for SSTIs at CMK ED received prescriptions for 5 days or less.
Aim Statement:
Increase the percentage of pediatric patients seen in the CMK ED
receiving outpatient antibiotic prescriptions for uncomplicated SSTIs for
durations of 5 days or less from 4% to 25% by January 2018, to 50% by
July 2018, w ith an end goal of 80% by January 2019.

Results and Analysis
Providers w ere initially introduced to the project in October 2016. The
changes to the antibiotic prescription orders in the EMR w ere completed in
July 2017. Providers started receiving individual feedback on performance
in August 2018 (given data from April 2018 and monthly updates). The
prescribing rate of short course antibiotics increased to greater than 25%
by August 2017 and greater than 50% by April 2018. The rate w as 58% in
the most recent month (July 2018). Six patients have returned for
admission for IV antibiotics w ithin 28 days of initial visit, but all w ere
prescribed longer duration of antibiotics at diagnosis (7 days of antibiotic
or more). There w ere 4 failures in the baseline data. Overall, there has
been an improvement in the prescribing trends of providers at CMK ED for
uncomplicated SSTIs. Data collection and interventions continue and it is
anticipated that compliance w ith the recommendations w ill continue to
improve as providers review summaries of prescribing practices.

Conclusion
Since initiation of this project, there has been marked improvement and
now 58% of pediatric patients diagnosed w ith uncomplicated SSTIs are
being prescribed antibiotics for 5 days or less, consistent w ith current
practice guidelines. This has greatly enhanced antibiotic stew ardship by
reducing unnecessarily long durations of treatment.

Barriers and Limitations
Barriers:
Challenges included a transition to ICD-10 and multiple updates to the
electronic medical record (EMR), w hich impacted data collection and review.
Due to this challenge, it took longer than anticipated for some interventions.
Lim itations:
Failure analysis is limited to patients seen at Children's Mercy facilities and
does not consider patients seen by primary care providers or admitted at
other hospitals in the area.

Future Goals
1.
2.
3.
4.
5.

Continue to make changes to reach goal of 80% by January 2019.
Monitor progress and assess sustainability.
Propagation to Adele Hall ED and CMH Urgent Cares if interested.
Use the know ledge gained in future QI projects.
Ensure new staff are educated on guidelines and project goals.
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